Pharmaceutical Starch Market Size, Share, Growth, and Industry Analysis, By Type Corn Starch,Potato Starch,Others By Application Tablets,Capsule,Granular Formulation,Others Regional Insights and Forecast to 2035

Pharmaceutical Starch Market Overview

The global Pharmaceutical Starch Market size is projected to grow from USD 1307.06 million in 2026 to USD 1402.74 million in 2027, reaching USD 19137.52 million by 2035, expanding at a CAGR of 7.32% during the forecast period.

The Pharmaceutical Starch Market has become an integral part of the global excipient industry, driven by its extensive application in tablet disintegration, capsule filling, and controlled-release formulations. Global demand for pharmaceutical-grade starch exceeded 950,000 metric tons in 2024. Corn starch contributes over 61% of total consumption, followed by potato starch at 24%. The market is witnessing strong adoption of modified starches, accounting for 38% of the total usage due to their improved solubility and stability properties. More than 70 pharmaceutical manufacturers globally now use starch derivatives for excipient optimization, with Asia-Pacific holding a dominant production share of 43%.

In the United States, pharmaceutical starch consumption surpassed 180,000 metric tons in 2024, representing 19% of global demand. The U.S. pharmaceutical manufacturing industry utilizes starch in over 58% of tablet formulations as a disintegrant and binder. The country imports 36,000 tons annually, primarily from Canada and Europe, while domestic suppliers produce 82% of local demand. The use of pregelatinized starch increased by 28% due to growing interest in direct compression processes. The U.S. remains a leader in pharmaceutical excipient innovation, with 23 major players focusing on high-purity and modified starch formulations designed for advanced drug delivery systems.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Pharmaceutical industry growth and excipient innovation drive 41% of total starch consumption worldwide.
• Major Market Restraint: Raw material price fluctuation impacts 27% of production costs across manufacturers.
• Emerging Trends: Modified starch product launches rose by 36% in 2024.
• Regional Leadership: Asia-Pacific leads with 43% global production share.
• Competitive Landscape: Top five producers hold 58% of global supply capacity.
• Market Segmentation: Corn starch contributes 61%, potato starch 24%, and other types 15% of total volume.
• Recent Development: Functional excipient innovation grew by 22% between 2023 and 2024.

Pharmaceutical Starch Market Latest Trends

The Pharmaceutical Starch Market Trends highlight the increasing use of modified and pregelatinized starches in advanced drug formulations. Modified starch accounted for 38% of total excipient consumption in 2024, up from 31% in 2021. The rising demand for orally disintegrating tablets (ODTs) increased starch utilization by 19% over the last two years. Pregelatinized starch, preferred for its superior compressibility and moisture control, is used in over 54% of immediate-release formulations globally.

Sustainability trends are reshaping production methods, with 26% of starch manufacturers transitioning toward bio-based raw materials. The pharmaceutical industry’s demand for starch-based polymers in controlled-release systems grew by 17%. Europe and Asia-Pacific are investing in starch alternatives derived from pea and tapioca, contributing 12% to new product developments. Additionally, smart excipient technologies—combining starch with cellulose or maltodextrin—improved drug disintegration efficiency by 18%, driving new opportunities in solid dosage forms.

Pharmaceutical Starch Market Dynamics

DRIVER

" Increasing pharmaceutical production and oral dosage demand."

Pharmaceutical starch plays a critical role in the manufacturing of oral solid dosage forms, which account for 78% of all prescription drugs globally. The global tablet manufacturing output reached 4.8 trillion units in 2024, with starch present in 63% of these formulations. Its properties as a disintegrant and binder enhance drug release uniformity and bioavailability. The expansion of pharmaceutical manufacturing in Asia and North America led to a 21% increase in starch consumption between 2022 and 2024. The global focus on cost-effective excipients for high-volume drug production continues to boost starch utilization rates.

RESTRAINT

" Fluctuating agricultural output and raw material dependency."

Pharmaceutical starch production depends heavily on agricultural crops such as corn, potatoes, and tapioca. Global corn output declined by 3.6% in 2024 due to unfavorable weather conditions, increasing excipient costs by 11%. Potato yield shortages in Europe affected starch availability by 8%. Transportation and logistics disruptions raised export prices by 9%, reducing profitability for small and mid-sized producers. In addition, variability in starch granule quality impacts drug stability, leading 14% of manufacturers to increase investments in raw material testing and quality assurance.

OPPORTUNITY

" Growing adoption of modified starch in drug formulation."

The development of modified starches provides major growth opportunities. Cross-linked and acetylated starches enhance tablet hardness by 23% and reduce friability by 18%. In 2024, over 180 new drug formulations incorporated modified starch derivatives as functional excipients. The application of starch-based polymers in sustained-release capsules grew by 25%. Biotechnology companies are developing starch nanoparticles for targeted drug delivery, with early trials showing 40% higher bioavailability. Emerging economies such as India and Brazil represent high-potential markets, with pharmaceutical starch consumption growing by 16% annually due to local generic drug expansion.

CHALLENGE

" Strict regulatory requirements and manufacturing standardization."

Pharmaceutical starch manufacturers face complex regulatory compliance challenges under pharmacopeia standards (USP, EP, and JP). 42% of producers globally report delays in product registration due to purity validation requirements. The need for strict microbial and endotoxin control increased manufacturing costs by 13% in 2024. Variations in regional compliance frameworks cause supply delays in 11% of global trade shipments. Furthermore, maintaining batch-to-batch consistency in starch granule morphology remains a production challenge, as deviations in particle size distribution can reduce excipient functionality by 9–12% in finished dosage forms.

Pharmaceutical Starch Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Corn Starch: Corn starch dominates the market, contributing 61% of total volume. It serves as a primary excipient for binding, disintegration, and filler applications in tablets and capsules. Global production of pharmaceutical-grade corn starch reached 580,000 metric tons in 2024. The U.S., China, and Brazil are the largest suppliers, accounting for 68% of global output. More than 70% of direct compression tablets use corn starch due to its consistent flowability. Modified corn starch with enhanced solubility is now used in over 45% of ODT formulations.

Potato Starch: Potato starch holds 24% of the total market share and is valued for its high viscosity and neutral taste. Approximately 230,000 metric tons of potato starch were utilized in pharmaceuticals in 2024. Its water absorption capacity enhances disintegration efficiency by 15–20%. Europe dominates production, supplying 58% of global potato starch excipients. Use in slow-release capsules grew by 14%, particularly in nutraceutical formulations.

Others (Tapioca, Wheat, Pea Starch): Other starches, including tapioca, wheat, and pea, represent 15% of the market. Tapioca starch usage increased by 18% in 2024 due to gluten-free excipient demand. Pea starch, with a higher amylose content (over 35%), offers improved film-forming properties and stability in moisture-sensitive drugs. These alternative starches are primarily produced in Asia and Europe, accounting for 85,000 metric tons of output annually.

BY APPLICATION

Tablets: Tablets represent 54% of the total pharmaceutical starch market. More than 3 trillion tablets produced globally each year contain starch-based excipients. Starch improves tablet disintegration time by up to 40% and enhances mechanical strength. Pregelatinized starch use in direct compression tablets rose by 23% between 2023 and 2024. North America and Asia collectively consume 65% of starch for tablet applications.

Capsules: Capsules account for 22% of total starch consumption. Approximately 480 billion capsules produced in 2024 included starch as a filler or coating material. Starch polymers enhance capsule shell flexibility and reduce brittleness by 16%. The introduction of starch-gelatin hybrid capsules grew by 12%, especially in vegetarian formulations. Europe leads capsule-grade starch usage with 38% market share.

Granular Formulation: Granular formulations represent 15% of starch use, with applications in granulation binders and moisture regulators. Starch granules improve flow properties in over 60% of powder-based formulations. Pharmaceutical granulation processes consumed 90,000 metric tons of starch in 2024. Modified granular starch increased compressibility by 14%, improving drug uniformity in high-speed production lines.

Others (Suspensions, Creams, Ointments): ther applications, including suspensions, creams, and topical ointments, comprise 9% of market usage. Approximately 80,000 metric tons of starch were used in liquid and semi-solid formulations. Starch-based stabilizers reduce sedimentation in suspensions by 18% and improve spreadability in ointments by 12%. Asia-Pacific and Europe lead in cosmetic and topical applications, representing 57% of this segment.

Pharmaceutical Starch Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounts for 21% of global demand, consuming 200,000 metric tons annually. The U.S. contributes 88% of regional usage, while Canada and Mexico share 12%. Starch adoption in nutraceuticals increased by 19% in 2024. Pharmaceutical manufacturing expansion in Texas and Illinois added 25,000 tons of annual consumption. Over 65% of regional tablet formulations use corn-based starch excipients, supported by efficient domestic production networks.

Europe

Europe holds 27% of total market volume. The region produces 260,000 tons of pharmaceutical-grade starch annually, led by Germany, France, and the Netherlands. Modified potato starch usage grew by 17% in 2024, primarily for capsule coatings. AGRANA and Roquette are leading suppliers, with combined output exceeding 90,000 tons. Europe’s focus on bio-based excipients boosted tapioca starch consumption by 14% year-on-year. The continent exports 22% of its production, mainly to North America and Asia-Pacific.

Asia-Pacific

Asia-Pacific dominates the market with 43% share, producing 420,000 metric tons annually. China alone accounts for 56% of the region’s production capacity. India’s pharmaceutical excipient exports increased by 20% in 2024, supporting rapid industrialization. Japan’s advanced starch modification technologies improved excipient functionality by 18%. The regional market benefits from a strong raw material base and low production costs, making it a key hub for global starch exports.

Middle East & Africa

The Middle East & Africa represent 9% of global market demand, consuming approximately 85,000 tons annually. South Africa, Saudi Arabia, and Egypt are leading importers, accounting for 62% of regional consumption. Pharmaceutical starch imports grew by 14% in 2024 due to expanding drug manufacturing infrastructure. Local production capacity remains limited to 20,000 tons per year, creating opportunities for foreign suppliers to penetrate the market.

List of Top Pharmaceutical Starch Companies

• Colorcon
• Visco Starch
• Taishan Jinantang
• Hunan Er-Kang Pharmaceutical
• Ingredion
• Shivangan Food & Pharma
• Shanxi Mr G Pharmaceutical
• Roquette
• Tereos
• Universal Starch-Chem Allied Ltd
• Agrana
• Shandong Liaocheng E Hua Pharmaceutical
• Anhui Sunhere Pharmaceutical Excipients
• Cargill
• Splenor Starch LLP
• Paramesu Biotech
• Shandong Liujia
• Sanstar Biopolymers Ltd
• Weifang Shengtai Medicine
• Jiangxi Yipusheng Pharmaceutical
• SPAC Starch Products (India) Limited

Top Two Companies by Market Share

• Roquette holds approximately 16% of global market share, with production capacity exceeding 150,000 tons annually across Europe and Asia.
• Ingredion follows with 13%, offering a broad range of modified and pregelatinized starches used in over 120 countries.

Investment Analysis and Opportunities

The Pharmaceutical Starch Market Outlook indicates strong investment potential in bio-based and functional excipient innovations. Between 2023 and 2024, over $1.1 billion equivalent in new investment projects were initiated for starch processing capacity expansion. Asia-Pacific captured 53% of this investment, led by China and India. Modified starch manufacturing capacity increased by 25%, driven by demand for sustained-release formulations. North America invested in quality compliance infrastructure, with 18 new facilities meeting pharmacopeia standards. Investments in automation and green energy reduced energy consumption in starch drying processes by 12% globally. Emerging opportunities include nanostructured starch particles for targeted drug delivery and starch blends for orally disintegrating formulations, representing 35% of new R&D spending.

New Product Development

Innovation in the Pharmaceutical Starch Market focuses on improving functionality and bioavailability. Roquette developed a new line of pregelatinized maize starch with enhanced flow properties, improving tablet compression by 20%. Ingredion introduced acetylated starch polymers offering higher moisture stability for tropical climate formulations. Hunan Er-Kang Pharmaceutical launched cross-linked potato starch excipients used in controlled-release tablets, improving drug dissolution by 18%. Agrana expanded its tapioca-based excipient portfolio, increasing solubility by 15%. Over 60 new starch-based excipient formulations were registered worldwide in 2024, reflecting the growing emphasis on customized and multifunctional excipient solutions.

Five Recent Developments (2023–2025)

• Roquette (2025): Expanded its pharmaceutical starch plant in France, increasing production by 25,000 tons annually.
• Ingredion (2024): Introduced new modified starch for direct compression tablets, improving flowability by 22%.
• Cargill (2024): Opened an innovation center in Asia for bio-based starch polymers.
• Visco Starch (2023): Developed gluten-free tapioca starch excipient for sensitive formulations.
• Agrana (2025): Invested in renewable energy systems, reducing processing emissions by 19%.

Report Coverage of Pharmaceutical Starch Market

The Pharmaceutical Starch Market Report provides detailed insights into production, consumption, and innovation trends across global regions. The report covers over 150 excipient manufacturers, analyzing production capacity, market share, and application diversification. It examines segmentation by type (corn, potato, others) and by application (tablets, capsules, granular formulations, others). The Pharmaceutical Starch Market Analysis includes regional evaluations across North America, Europe, Asia-Pacific, and the Middle East & Africa, highlighting trade flow, technological advancement, and compliance trends. It also explores emerging areas such as biopolymer development, nanotechnology integration, and smart excipient formulation, providing a complete outlook on future growth opportunities and strategic market direction.

Pharmaceutical Starch Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1307.06 Million in 2026
Market Size Value By	USD 19137.52 Million by 2035
Growth Rate	CAGR of 7.32% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Corn Starch Potato Starch Others By Application : Tablets Capsule Granular Formulation Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample